FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743443902> ?p ?o ?g. }

• W2743443902 endingPage "298" @default.
• W2743443902 startingPage "290" @default.
• W2743443902 abstract "Objective:This study was conducted to examine the effect of structured education on medication adherence and self-efficacy through the use of the MASCC Oral Agent Teaching Tool (MOATT) for patients receiving oral agents for cancer treatment.Methods:This quasi-experimental study has been conducted at two hospitals; 41 patients were included in the study. Data were obtained using a questionnaire, medication adherence self-efficacy scale (MASES), memorial symptom assessment scale, and a follow-up form (diary). Patients were educated through the use of the MOATT at a scheduled time; drug-specific information was provided along with a treatment scheme and follow-up diary. Phone interviews were completed 1 and 2 weeks after the educational session. At the next treatment cycle, the patients completed the same questionnaires.Results: Majority of the patients were receiving capecitabine (90.2%; n = 37) as an oral agent for breast (51.2%; n = 21) and stomach cancer (24.6%; n = 10) treatment. About 90.2% of patients (n = 37) stated that they did not forget to take their medication and experienced medication-related side effects (78%; n = 32). The total score of MASES was increased after the education (66.39 vs. 71.04, P < 0.05).Conclusions:It was shown that individual education with the MOATT and follow-up for patients receiving oral agents for cancer treatment increased patient medication adherence self-efficacy. This study was conducted to examine the effect of structured education on medication adherence and self-efficacy through the use of the MASCC Oral Agent Teaching Tool (MOATT) for patients receiving oral agents for cancer treatment. This quasi-experimental study has been conducted at two hospitals; 41 patients were included in the study. Data were obtained using a questionnaire, medication adherence self-efficacy scale (MASES), memorial symptom assessment scale, and a follow-up form (diary). Patients were educated through the use of the MOATT at a scheduled time; drug-specific information was provided along with a treatment scheme and follow-up diary. Phone interviews were completed 1 and 2 weeks after the educational session. At the next treatment cycle, the patients completed the same questionnaires. : Majority of the patients were receiving capecitabine (90.2%; n = 37) as an oral agent for breast (51.2%; n = 21) and stomach cancer (24.6%; n = 10) treatment. About 90.2% of patients (n = 37) stated that they did not forget to take their medication and experienced medication-related side effects (78%; n = 32). The total score of MASES was increased after the education (66.39 vs. 71.04, P < 0.05). It was shown that individual education with the MOATT and follow-up for patients receiving oral agents for cancer treatment increased patient medication adherence self-efficacy." @default.
• W2743443902 created "2017-08-17" @default.
• W2743443902 creator A5014621289 @default.
• W2743443902 creator A5046190554 @default.
• W2743443902 date "2017-10-01" @default.
• W2743443902 modified "2023-10-17" @default.
• W2743443902 title "The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy" @default.
• W2743443902 cites W1530430185 @default.
• W2743443902 cites W1843179041 @default.
• W2743443902 cites W1899969323 @default.
• W2743443902 cites W1947481365 @default.
• W2743443902 cites W1965855507 @default.
• W2743443902 cites W1971437486 @default.
• W2743443902 cites W1972706803 @default.
• W2743443902 cites W1991181910 @default.
• W2743443902 cites W1995705474 @default.
• W2743443902 cites W2010448000 @default.
• W2743443902 cites W2011774303 @default.
• W2743443902 cites W2013140691 @default.
• W2743443902 cites W2019142261 @default.
• W2743443902 cites W2027599452 @default.
• W2743443902 cites W2030901027 @default.
• W2743443902 cites W2032163464 @default.
• W2743443902 cites W2032655930 @default.
• W2743443902 cites W2034072525 @default.
• W2743443902 cites W2043560024 @default.
• W2743443902 cites W2045087507 @default.
• W2743443902 cites W2050861645 @default.
• W2743443902 cites W2070735224 @default.
• W2743443902 cites W2070741569 @default.
• W2743443902 cites W2080827051 @default.
• W2743443902 cites W2090955619 @default.
• W2743443902 cites W2094144150 @default.
• W2743443902 cites W2102980084 @default.
• W2743443902 cites W2106373540 @default.
• W2743443902 cites W2119824367 @default.
• W2743443902 cites W2125446695 @default.
• W2743443902 cites W2139062201 @default.
• W2743443902 cites W2140144216 @default.
• W2743443902 cites W2140737508 @default.
• W2743443902 cites W2166444516 @default.
• W2743443902 cites W2285690900 @default.
• W2743443902 cites W2322544914 @default.
• W2743443902 cites W2587267028 @default.
• W2743443902 cites W2775001788 @default.
• W2743443902 cites W4256042181 @default.
• W2743443902 cites W4292808503 @default.
• W2743443902 doi "https://doi.org/10.4103/apjon.apjon_35_17" @default.
• W2743443902 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5559938" @default.
• W2743443902 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28966956" @default.
• W2743443902 hasPublicationYear "2017" @default.
• W2743443902 type Work @default.
• W2743443902 sameAs 2743443902 @default.
• W2743443902 citedByCount "29" @default.
• W2743443902 countsByYear W27434439022017 @default.
• W2743443902 countsByYear W27434439022018 @default.
• W2743443902 countsByYear W27434439022019 @default.
• W2743443902 countsByYear W27434439022020 @default.
• W2743443902 countsByYear W27434439022021 @default.
• W2743443902 countsByYear W27434439022022 @default.
• W2743443902 countsByYear W27434439022023 @default.
• W2743443902 crossrefType "journal-article" @default.
• W2743443902 hasAuthorship W2743443902A5014621289 @default.
• W2743443902 hasAuthorship W2743443902A5046190554 @default.
• W2743443902 hasBestOaLocation W27434439021 @default.
• W2743443902 hasConcept C121608353 @default.
• W2743443902 hasConcept C126322002 @default.
• W2743443902 hasConcept C1862650 @default.
• W2743443902 hasConcept C2777909004 @default.
• W2743443902 hasConcept C2777929519 @default.
• W2743443902 hasConcept C512399662 @default.
• W2743443902 hasConcept C526805850 @default.
• W2743443902 hasConcept C71924100 @default.
• W2743443902 hasConceptScore W2743443902C121608353 @default.
• W2743443902 hasConceptScore W2743443902C126322002 @default.
• W2743443902 hasConceptScore W2743443902C1862650 @default.
• W2743443902 hasConceptScore W2743443902C2777909004 @default.
• W2743443902 hasConceptScore W2743443902C2777929519 @default.
• W2743443902 hasConceptScore W2743443902C512399662 @default.
• W2743443902 hasConceptScore W2743443902C526805850 @default.
• W2743443902 hasConceptScore W2743443902C71924100 @default.
• W2743443902 hasIssue "4" @default.
• W2743443902 hasLocation W27434439021 @default.
• W2743443902 hasLocation W27434439022 @default.
• W2743443902 hasLocation W27434439023 @default.
• W2743443902 hasLocation W27434439024 @default.
• W2743443902 hasLocation W27434439025 @default.
• W2743443902 hasOpenAccess W2743443902 @default.
• W2743443902 hasPrimaryLocation W27434439021 @default.
• W2743443902 hasRelatedWork W1990887842 @default.
• W2743443902 hasRelatedWork W2025705843 @default.
• W2743443902 hasRelatedWork W2093907075 @default.
• W2743443902 hasRelatedWork W2168295721 @default.
• W2743443902 hasRelatedWork W2342360757 @default.
• W2743443902 hasRelatedWork W2403098082 @default.
• W2743443902 hasRelatedWork W2463672529 @default.
• W2743443902 hasRelatedWork W2803690458 @default.
• W2743443902 hasRelatedWork W2887571236 @default.

• next